You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.


( ay-za-SYE-ti-deen )
New Drug Funding Program
  • Azacitidine - Acute Myeloid Leukemia (AML)
  • Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)
  • Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30% Blasts
Other Name(s): Vidaza®
Appearance: White, milky suspension for injection

You might also be interested in